Literature DB >> 27904960

Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases.

Christian Barmeyer1, Michael Fromm1, Jörg-Dieter Schulzke2.   

Abstract

Intestinal inflammatory diseases, four of which are discussed here, are associated with alterations of claudins. In ulcerative colitis, diarrhea and antigen entry into the mucosa occurs. Claudin-2 is upregulated but data on other claudins are still limited or vary (e.g., claudin-1 and -4). Apart from that, tight junction changes contribute to diarrhea via a leak flux mechanism, while protection against antigen entry disappears behind epithelial gross lesions (erosions) and apoptotic foci. Crohn's disease is additionally characterized by a claudin-5 and claudin-8 reduction which plays an active role in antigen uptake already before gross lesions appear. In microscopic colitis (MC), upregulation of claudin-2 expression is weak and a reduction in claudin-4 may be only passively involved, while sodium malabsorption represents the main diarrheal mechanism. However, claudin-5 is removed from MC tight junctions which may be an active trigger for inflammation through antigen uptake along the so-called leaky gut concept. In celiac disease, primary barrier defects are discussed in the context of candidate genes as PARD3 which regulate cell polarity and tight junctions. The loss of claudin-5 allows small antigens to invade, while the reductions in others like claudin-3 are rather passive events. Taken together, the specific role of single tight junction proteins for the onset and perpetuation of inflammation and the recovery from these diseases is far from being fully understood and is clearly dependent on the stage of the disease, the background of the other tight junction components, the transport activity of the mucosa, and the presence of other barrier features like gross lesions, an orchestral interplay which is discussed in this article.

Entities:  

Keywords:  Barrier defect; Celiac disease; Claudins; Crohn’s disease; Microscopic colitis; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 27904960     DOI: 10.1007/s00424-016-1914-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  110 in total

1.  Study of claudin function by RNA interference.

Authors:  Jianghui Hou; Antonio S Gomes; David L Paul; Daniel A Goodenough
Journal:  J Biol Chem       Date:  2006-10-03       Impact factor: 5.157

2.  Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients.

Authors:  Roberta Caruso; Irene Marafini; Silvia Sedda; Giovanna Del Vecchio Blanco; Paolo Giuffrida; Thomas T MacDonald; Gino Roberto Corazza; Francesco Pallone; Antonio Di Sabatino; Giovanni Monteleone
Journal:  Clin Sci (Lond)       Date:  2014-03       Impact factor: 6.124

3.  Increase in the tight junction protein claudin-1 in intestinal inflammation.

Authors:  Lisa S Poritz; Leonard R Harris; Ashley A Kelly; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2011-07-12       Impact factor: 3.199

4.  ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene.

Authors:  Lei Yuan; Alexandra Le Bras; Anastasia Sacharidou; Kiyoshi Itagaki; Yumei Zhan; Maiko Kondo; Christopher V Carman; George E Davis; William C Aird; Peter Oettgen
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

5.  Transforming growth factor-β, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells.

Authors:  Nina A Hering; Susanne Andres; Anja Fromm; Eric A van Tol; Maren Amasheh; Joachim Mankertz; Michael Fromm; Joerg D Schulzke
Journal:  J Nutr       Date:  2011-03-23       Impact factor: 4.798

6.  TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling.

Authors:  Maren Amasheh; Anja Fromm; Susanne M Krug; Salah Amasheh; Susanne Andres; Martin Zeitz; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Cell Sci       Date:  2010-11-09       Impact factor: 5.285

7.  Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis.

Authors:  M C Wapenaar; A J Monsuur; A A van Bodegraven; R K Weersma; M R Bevova; R K Linskens; P Howdle; G Holmes; C J Mulder; G Dijkstra; D A van Heel; C Wijmenga
Journal:  Gut       Date:  2007-11-07       Impact factor: 23.059

8.  Enhancement of barrier function by overexpression of claudin-4 in tight junctions of submandibular gland cells.

Authors:  Hiromi Michikawa; Junko Fujita-Yoshigaki; Hiroshi Sugiya
Journal:  Cell Tissue Res       Date:  2008-10-15       Impact factor: 5.249

9.  Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.

Authors:  H-J Epple; T Schneider; H Troeger; D Kunkel; K Allers; V Moos; M Amasheh; C Loddenkemper; M Fromm; M Zeitz; J-D Schulzke
Journal:  Gut       Date:  2008-10-20       Impact factor: 23.059

10.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.

Authors:  Mikio Furuse; Masaki Hata; Kyoko Furuse; Yoko Yoshida; Akinori Haratake; Yoshinobu Sugitani; Tetsuo Noda; Akiharu Kubo; Shoichiro Tsukita
Journal:  J Cell Biol       Date:  2002-03-11       Impact factor: 10.539

View more
  22 in total

Review 1.  Claudins: vital partners in transcellular and paracellular transport coupling.

Authors:  Dorothee Günzel
Journal:  Pflugers Arch       Date:  2016-11-25       Impact factor: 3.657

2.  Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.

Authors:  Qinghong Dan; Yixuan Shi; Razieh Rabani; Shruthi Venugopal; Jenny Xiao; Shaista Anwer; Mei Ding; Pam Speight; Wanling Pan; R Todd Alexander; András Kapus; Katalin Szászi
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

Review 3.  Microscopic colitis-microbiome, barrier function and associated diseases.

Authors:  Saskia van Hemert; Karolina Skonieczna-Żydecka; Igor Loniewski; Piotr Szredzki; Wojciech Marlicz
Journal:  Ann Transl Med       Date:  2018-02

Review 4.  Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.

Authors:  Susana Lechuga; Andrei I Ivanov
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-03-18       Impact factor: 4.739

Review 5.  Mechanism of Acupuncture and Moxibustion on Promoting Mucosal Healing in Ulcerative Colitis.

Authors:  Han Li; Xiao-Feng Ye; Yang-Shuai Su; Wei He; Jian-Bin Zhang; Qi Zhang; Li-Bin Zhan; Xiang-Hong Jing
Journal:  Chin J Integr Med       Date:  2022-04-12       Impact factor: 1.978

6.  Claudin-2 pore causes leak that breaches the dam in intestinal inflammation.

Authors:  Kim E Barrett
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

7.  Histone H3K9 methylation regulates chronic stress and IL-6-induced colon epithelial permeability and visceral pain.

Authors:  John W Wiley; Ye Zong; Gen Zheng; Shengtao Zhu; Shuangsong Hong
Journal:  Neurogastroenterol Motil       Date:  2020-08-02       Impact factor: 3.598

8.  Mechanisms underlying reduced weight gain in intestinal fatty acid-binding protein (IFABP) null mice.

Authors:  Atreju I Lackey; Tina Chen; Yin X Zhou; Natalia M Bottasso Arias; Justine M Doran; Sophia M Zacharisen; Angela M Gajda; William O Jonsson; Betina Córsico; Tracy G Anthony; Laurie B Joseph; Judith Storch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-06       Impact factor: 4.052

9.  Molecular Characterization of Barrier Properties in Follicle-Associated Epithelium of Porcine Peyer's Patches Reveals Major Sealing Function of Claudin-4.

Authors:  Judith Radloff; Evgeny L Falchuk; Alexander G Markov; Salah Amasheh
Journal:  Front Physiol       Date:  2017-08-14       Impact factor: 4.566

10.  Non-Hematopoietic MLKL Protects Against Salmonella Mucosal Infection by Enhancing Inflammasome Activation.

Authors:  Shui-Xing Yu; Wei Chen; Zhen-Zhen Liu; Feng-Hua Zhou; Shi-Qing Yan; Gui-Qiu Hu; Xiao-Xia Qin; Jie Zhang; Ke Ma; Chong-Tao Du; Jing-Min Gu; Xu-Ming Deng; Wen-Yu Han; Yong-Jun Yang
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.